🇺🇸 FDA
Patent

US 11919887

Substituted tetrahydrofurans as modulators of sodium channels

granted A61PA61P29/00

Quick answer

US patent 11919887 (Substituted tetrahydrofurans as modulators of sodium channels) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P29/00